Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and internal validation of a novel predictive model for SDHB mutations in pheochromocytomas and retroperitoneal paragangliomas. | Front Endocrinol (Lausanne) | 2023 | 38179299 | PubTator, text mining | PubMed |
| Radiochemistry: A Hot Field with Opportunities for Cool Chemistry. | ACS Cent Sci | 2023 | 38161375 | PubTator, text mining | PubMed |
| DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair. | Pharmaceutics | 2023 | 38140100 | PubTator, text mining | PubMed |
| Special Issue: Evaluation of the Antitumor Mechanism of Armed Antibodies. | Pharmaceuticals (Basel) | 2023 | 38139816 | PubTator, text mining | PubMed |
| Expression of neuroendocrine markers predicts increased survival in triple-negative breast cancer patients. | Front Endocrinol (Lausanne) | 2023 | 38125789 | PubTator, text mining | PubMed |
| Phylogenetic Analysis Provides Insight Into the Molecular Evolution of Nociception and Pain-Related Proteins. | Evol Bioinform Online | 2023 | 38107163 | PubTator, text mining | PubMed |
| A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas. | Acta Neuropathol Commun | 2023 | 38102708 | PubTator, text mining | PubMed |
| Identifying CD1c as a potential biomarker by the comprehensive exploration of tumor mutational burden and immune infiltration in diffuse large B cell lymphoma. | PeerJ | 2023 | 38099311 | PubTator, text mining | PubMed |
| Case Report: Gastrointestinal neuroendocrine carcinoma with SMARCA4 deficiency: a clinicopathological report of two rare cases. | Front Oncol | 2023 | 38090508 | PubTator, text mining | PubMed |
| Large cell neuroendocrine carcinoma transformation: A novel acquired drug resistance mechanism in colorectal adenocarcinoma. | Cancer Innov | 2023 | 38090055 | PubTator, text mining | PubMed |
| Apoptosis-related factors are relevant to progression of pancreatic neuroendocrine tumors. | World J Surg Oncol | 2023 | 38082268 | PubTator, text mining | PubMed |
| Hotspots of Somatic Genetic Variation in Pituitary Neuroendocrine Tumors. | Cancers (Basel) | 2023 | 38067388 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance. | Cancers (Basel) | 2023 | 38067255 | PubTator, text mining | PubMed |
| Structure, function and drug discovery of GPCR signaling. | Mol Biomed | 2023 | 38047990 | PubTator, text mining | PubMed |
| Successful Treatment of Postprandial Hyperinsulinemic Hypoglycemia After Billroth-II Gastrojejunostomy Using Octreotide. | JCEM Case Rep | 2023 | 38045869 | PubTator, text mining | PubMed |
| Caution on the Use of 68Ga-DOTATATE for the Diagnosis of Pheochromocytoma: A Report of 2 Cases. | JCEM Case Rep | 2023 | 38045868 | PubTator, text mining | PubMed |
| Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly. | Arch Med Res | 2023 | 38042683 | PubTator, text mining | PubMed |
Retraction notice to "Overexpression of cortistatin alleviates oxygen/glucose-deprivation-induced ER stress and prompts neural stem cell proliferation via SSTR2" [Experimental and Molecular Pathology 113 (2020) 104351]. | Exp Mol Pathol | 2023 | 38040521 | PubTator, text mining | PubMed |
| Neuroendocrine neoplasms in the breast oncology field: dilemmas of nature and morphology. | Front Endocrinol (Lausanne) | 2023 | 38027104 | PubTator, text mining | PubMed |
| Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly. | Front Endocrinol (Lausanne) | 2023 | 38027102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=19